Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis

References

• Kahn PJ. Juvenile idiopathic arthritis: what the clinician needs to know. Bull NYU Hosp Jt Dis. 2013;71(3):194.
   Google Scholar
• Moued MM, Al-Saggaf HM, Habib HS, Muzaffer MA. Oligoarticular juvenile idiopathic arthritis among Saudi children. Ann Saudi Med. 2013;33(6): 529–32.
   PubMed Web of Science ®Google Scholar
• Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Pediatr Clin North Am. 2005;52(2):413–42, vi.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al.; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
   PubMed Web of Science ®Google Scholar
• Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al.; Nordic Study Group of Pediatric Rheumatology. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(9):2809–18.
   PubMedGoogle Scholar
• Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–84.
   PubMedGoogle Scholar
• Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder M-L, Cabral DA, et al. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46(10):2708–15.
   PubMedGoogle Scholar
• Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180–91.
   PubMed Web of Science ®Google Scholar
• Pelegrín L, Casaroli-Marano R, Antón J, García de Vicuña MC, Molina-Prat N, Ignacio Aróstegui J, et al. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2014;22(3):208–12.
   PubMed Web of Science ®Google Scholar
• Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010;21(6):468–72.
   PubMed Web of Science ®Google Scholar
• Ýlleez ÖG. Juvenile Idiopathic Artrhritis. BMJ 2018;5(1):42–6.
   Google Scholar
• Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Med J. 2017;34(2):90–101.
   PubMed Web of Science ®Google Scholar
• Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):23.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Paediatric Rheumatology International Trials Organisation. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(7):929–36.
   PubMed Web of Science ®Google Scholar
• Sawhney S, Agarwal M. Outcome measures in pediatric rheumatology. Indian J Pediatr. 2010;77(10):1183–9.
   PubMed Web of Science ®Google Scholar
• Ringold S, Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2007;19(5):471–6.
   PubMed Web of Science ®Google Scholar
• Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465–82.
   PubMed Web of Science ®Google Scholar
• Muller PH, et al. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study. Pediatr Rheumatol. 2017;15(1):11.
   PubMedGoogle Scholar
• van Dijkhuizen EHP, Aidonopoulos O, ter Haar NM, Pires Marafon D, Magni-Manzoni S, Ioannidis YE, et al. Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study. Rheumatology. 2018;57(10):1752–60.
   PubMed Web of Science ®Google Scholar
• Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N, et al.; ReACCh-Out investigators. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis. 2016;75(6):1092–8.
   PubMed Web of Science ®Google Scholar
• Guillaume S, Prieur A-M, Coste J, Job-Deslandre C. Long‐term outcome and prognosis in oligoarticular‐onset juvenile idiopathic arthritis. Arthritis Rheum. 2000;43(8):1858–65.
   PubMedGoogle Scholar
• Nalbanti P, Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Farmaki E, Bamidis P, et al. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment. Rheumatol Int. 2018;38(7):1241–50.
   PubMed Web of Science ®Google Scholar
• Batthish M, Berard R, Cabral D, Bolaria R, Chédeville G, Duffy C, et al.; for The Canadian Alliance of Pediatric Rheumatology Investigators. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry. Rheumatology (Oxford). 2020;59(10):2796–805.
   PubMed Web of Science ®Google Scholar
• Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77(3):336–42.
   PubMed Web of Science ®Google Scholar